Germany Covid-19 Vaccine Market - Forecast(2024 - 2030)

    1.1. No. of German Sites for Covid-19 vaccines by Type

    1.2. No. of Covid-19 Vaccine Production facilities in Germany by Production Type

    1.3. No. of Covid-19 Vaccine Production facilities in Germany by Vaccine Developer

    4.1. First Covid-19 Vaccination Dates by Vaccine Type Equivalent to Start/Launch date in Germany

    4.2. Covid-19 Vaccines Administration Percentages of fully Vaccinated People by Vaccine Type in Germany 2021-2022

    4.3. Covid-19 Cumulative Vaccination Doses by Type of Vaccines in Germany 2021-2022

    4.4. Covid-19 Pfizer BioNTech-Comirnaty Cumulative Vaccination in Germany 2021-2022

    4.5. Covid-19 Moderna-Spikevax Cumulative Vaccination in Germany 2021-2022

    4.6. Covid-19 AstraZeneca-Vaxzevria Cumulative Vaccination in Germany 2021-2022

    4.7. Covid-19 Janssen-Ad26.COV2.S Cumulative Vaccination in Germany 2021-2022

    4.8. Covid-19 First Dose Cumulative Vaccination in Germany 2021-2022

    4.9. Covid-19 Second Dose Cumulative Vaccination in Germany 2021-2022

    4.10. Covid-19 Booster Dose Cumulative Vaccination in Germany 2021-2022

    4.11. No. of People Vaccinated Fully by State in Germany (Million)

    4.12. No. of People Vaccinated fully by Proportion of the Population by State in Germany (%)

    4.13. No. of People Vaccinated at least once by State in Germany (Million)

    4.14. No. of People Vaccinated at least once by Proportion of the Population by State in Germany (%)

    4.15. No. of People Vaccinated with boosters by State in Germany (Million)

    4.16. No. of People Vaccinated with boosters by Proportion of the Population by State in Germany (%)

    4.17. Covid-19 Total Vaccinations Administered by No. of People in Germany 2021-2022 (Million)

    4.18. Covid-19 Total Vaccinations Administered by Proportion of the Population in Germany 2021-2022 (%)

    5.1. Covid-19 Funding Contribution by Germany by Pillar 2020-2021 (US$ Million)

    5.2. Covid-19 Funding Percentage Contribution by Germany by Pillar 2020-2021 (%)

    5.3. Germany's Value in Top Covid-19 R&D investments on Vaccines (US$ Billion)

    6.1. Covid-19 Vaccine Doses Sharing Through COVAX by Germany (Million Doses)

    6.2. Covid-19 Vaccine Donations by Germany 2021 (Million Doses)

    7.1. Top3 Imports of Covid-19 Critical Products to Germany for first half of the year 2020 (US$ Million)

    7.2. Top3 Imports Growth Rate (%) of Covid-19 Critical Products to Germany for first half of the year 2020

    7.3. Share (%) of Top3 Imports of Total Covid-19 Critical Products to Germany for first half of the year 2020

    7.4. Top2 Exports of Covid-19 Critical Products from Germany for first half of the year 2020 (US$ Million)

    7.5. Top2 Exports Growth Rate (%) of Covid-19 Critical Products from Germany for first half of the year 2020

    7.6. Share (%) of Top2 Exports of Total Covid-19 Critical Products from Germany for first half of the year 2020

    7.7. Germany’s Value in World's Top Exporters of Covid-19 Critical Products during the first half of 2020 (US$ Million)

    7.8. Germany’s Growth Rate (%) Value in World's Top Exporters of Covid-19 Critical Products during the first half of 2020

    7.9. Germany’s Value Share (%) of World's Top Exporters of Covid-19 Critical Products during the first half of 2020

    7.10. Germany’s Value in World's Top Importers of Covid-19 Critical Products during the first half of 2020 (US$ Million)

    7.11. Germany’s Growth Rate (%) Value in World's Top Importers of Covid-19 Critical Products during the first half of 2020

    7.12. Germany’s Share (%) of World's Top Importers of Covid-19 Critical Products during the first half of 2020

    7.13. Germany's Value in Importing Face Masks from China during the first half of 2020 (US$ Million)

    7.14. Germany's Share (%) in Importing Face Masks from China during the first half of 2020

    8.1. Arrival of First Covid-19 Variants Equivalent to First Case in Germany

    8.2. Covid-19 No. of Cases in Germany 2020-2022

    8.3. Covid-19 Cases Growth Rate (%) in Germany 2020-2022

    8.4. Covid-19 Cumulative Cases in Germany 2020-2022

    8.5. Covid-19 Cases by Age Group and Gender in Germany 2020-2022

    8.6. Covid-19 Cases by Age Group and Sex/100,000 population in Germany 2020-2022

    8.7. Covid-19 Cases by Federal State in Germany 2020-2022

    10.1. Prevalence Rate (%) of Covid-19 Disease in Germany 2020-2022

    10.2. Cumulative Prevalence Rate (%) of Covid-19 Disease in Germany 2020-2022

    10.3. Prevalence Rate (%) Status of Covid-19 Disease and Covid-19 Deaths in Germany

    11.1. Covid-19 Major Diagnostic Test Kits Manufacturers of Germany

    11.2. Major Surgical Mask Manufacturers in Germany

    12.1. Covid-19 Deaths in Germany 2020-2022

    12.2. Covid-19 Deaths Growth Rate (%) in Germany 2020-2022

    12.3. Covid-19 Cumulative Deaths in Germany 2020-2022

    12.4. Covid-19 Deaths by Age Group and Gender in Germany 2020-2022

    12.5. Covid-19 Deaths by Age Group and Sex/100,000 population in Germany 2020-2022

    12.6. Covid-19 Deaths by Federal State in Germany 2020-2022

    12.7. Covid-19 Fatality Rate (%) in Germany 2020-2022

    13.1. Covid-19 Effect on GDP Change (%) in Germany 2020-2021

    13.2. Covid-19 Effect on GDP Change (%) on Previous Quarter in Germany 2020-2021

    13.3. Covid-19 Effect on GDP Change (%) on Same Quarter a year earlier in Germany 2020-2021

    14.1. No. of Clinical trials of Covid-19 in Germany 2019-2022

    14.2. No. of Clinical trials of Covid-19 in Germany by Phases 2019-2022

    14.3. Percentage (%) of Clinical trials of Covid-19 in Germany by Age 2019-2022  

    14.4. Percentage (%) of Clinical trials of Covid-19 in Germany by Gender 2019-2022

    14.5. No. of Clinical trials of Covid-19 in Germany by Funding Type 2019-2022

    14.6. No. of Clinical trials of Covid-19 in Germany by Status 2019-2022

    14.7. No. of Clinical trials of Covid-19 in Germany by Study Type 2019-2022

    14.8. No. of Clinical trials of Covid-19 in Germany by Study Documents 2019-2022

    15.1. Covid-19 Vaccines Approved for Use in Germany 2020-2022

    15.2. Clinical Trials on Covid-19 Vaccines by Vaccine Type in Germany 2020-2022

    15.3. Ongoing Clinical Trials on Covid-19 Vaccines and its Status in Germany 2020-2022

    16.1. Covid-19 Patent documents by Type in Germany 2019-2022

    16.2. Covid-19 Patent Legal Status in Germany2019-2022

    16.3. Covid-19 Patent documents by Published, Filed and Granted Date in Germany 2019-2022

    16.4. Covid-19 Patent documents by Published Date in Germany 2019-2022

    16.5. Covid-19 Patent documents by Filing Date in Germany 2019-2022

    16.6. Covid-19 Patent documents by Granted Date in Germany 2019-2022

    16.7. Covid-19 Major Applicants in Germany 2019-2022

    16.8. Covid-19 Major Inventors in Germany 2019-2022

    16.9. Covid-19 Patents and its Details in Germany 2019-2022  

    17.1. Covid-19 University Level Studies by year in Germany 2020-2022

    17.2. Covid-19 University Level Studies by Publication Type in Germany 2020-2022

    17.3. Top Publishers of Covid-19 University Level Studies by Document Count in Germany 2020-2022

    17.4. Type of Funding in University Level Studies of Covid-19 in Germany 2020-2022 (%)

    18.1. Covid-19 Testing Rate (%) in Proportion of Population in Germany 2020-2021

    18.2. Covid-19 Positivity Rate (%) in Germany 2020-2021